We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Test Could Detect Infection Exposure History

By LabMedica International staff writers
Posted on 02 Feb 2026

Every infection leaves a lasting imprint on the immune system, but current diagnostic tools can usually detect exposure to only one pathogen at a time. More...

This makes it difficult to understand a person’s full infection history or immune protection using a simple test. Because immune responses vary widely between individuals, this diagnostic potential remains largely untapped. Researchers are now working toward a blood-based approach that could reconstruct lifelong exposure to infections by reading immune cell signatures.

T-cells detect infections through highly specific surface sensors known as T-cell receptors, each designed to bind a particular antigen. When a matching antigen is encountered, the corresponding T-cells multiply rapidly. While most die after clearing the infection, a subset remains as memory T-cells, preserving a record of that encounter. Researchers at the University of Erlangen-Nuremberg (FAU, Erlangen, Germany), in collaboration with the University Hospital Erlangen (Erlangen, Germany), have shown that exposure to a pathogen leads to the expansion of many T-cell clones, creating detectable patterns in the blood.

Although individual T-cell receptors differ greatly between people, infections often generate shared or even identical receptor sequences across multiple individuals. These recurring patterns form what researchers describe as an immunological fingerprint. By comparing T-cell receptor sequences from individuals with confirmed past infections, the team aims to identify receptor features specific to particular pathogens. Machine learning algorithms will be used to analyze these large datasets and link receptor patterns to known infectious diseases.

The researchers are initially focusing on viruses that can cause complications during pregnancy, such as rubella. One goal is to assess whether vaccinated or previously infected individuals, including pregnant women, still retain protective immunity by analyzing their T-cell profiles. This approach could complement or even extend beyond traditional antibody-based serological tests. In the long term, the team plans to build libraries of pathogen-specific T-cell receptors and contribute to a global database. This could allow a single blood test to provide a comprehensive overview of an individual’s infection history and immune status across their lifetime.

“Each infection leaves a trace in the immune system. For example, if you have ever had the flu, you will have more T-cells whose receptors match the flu virus antigens than someone who has not.” said Professor Kilian Schober, PhD, lead investigator. “In future, a single test may be sufficient to illustrate an individual’s infection history over their entire lifetime.”

Related Links:
FAU
University Hospital Erlangen


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Sample Transportation System
Tempus1800 Necto
Hemodynamic System Monitor
OptoMonitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.